Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

DIRECTOR DEALINGS: Aston Martin non-exec buys GBP1.7 million in shares

8th Nov 2021 14:39

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Monday and not separately reported by Alliance News:

----------

Aston Martin Lagonda Global Holdings PLC - Warwick-based luxury carmaker - Non-Executive Director Michael de Picciotto buys 100,000 shares via Saint James Invest SA at GBP17.44, worth GBP1.7 million, on Friday last week. Aston Martin on Thursday had said it is on track to meet its medium-term goals, with production of its Valkyrie supercar scaling up. In the first nine months of 2021, Aston Martin recorded a pretax loss of GBP188.6 million, sharply narrowed from GBP307.9 million a year before. In the third quarter alone, however, its loss widened to GBP97.9 million from GBP80.5 million a year before.

----------

EKF Diagnostics Holdings PLC - Cardiff-based diagnostics and central laboratory assay maker - Non-Executive Deputy Chair Julian Baines sells 250,000 shares at 80.76p, worth GBP201,900, on Monday. Retains 1.6 million shares, a 0.4% stake.

----------

Whitbread PLC - Dunstable, Bedfordshire-based hospitality provider - Tracey Ewins, associate of Simon Ewins, managing director of Premier Inn UK, sells 2,000 shares at GBP33.79, worth GBP67,580, on Friday. Simon Ewins had exercised options over 15,475 shares and sold all of them for GBP515,318 late last month.

----------

Yamana Gold Inc - Toronto-based miner in Canada and Brazil - Chief Executive Officer Daniel Racine buys 15,000 shares at CAD5.15, worth CAD77,280, about GBP45,830, on Friday.

----------

Headlam Group PLC - Birmingham-based floor coverings distributor - Independent Non-Executive Director Simon King buys 5,394 shares at 461p, worth GBP24,866, on Friday.

----------

Bivictrix Therapeutics PLC - Macclesfield, England-based drug development company specialising in cancer treatments - Non-Executive Director Robert Hawkins buys 100,000 shares at average 22.99p, worth GBP22,990, on Tuesday to Thursday last week. Now has 225,000 shares, a 0.3% stake.

----------

By Tom Waite; [email protected]

Copyright 2021 Alliance News Limited. All Rights Reserved.


Related Shares:

HeadlamWhitbreadEkf DiagnosticsAston Martin LagondaAUY.LBVX.L
FTSE 100 Latest
Value8,809.74
Change53.53